Literature DB >> 2349198

The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.

A Flatt1, J Crane, G Purdie, T Kwong, R Beasley, C Burgess.   

Abstract

The cardiovascular effects of equal doses (5 mg) of nebulised fenoterol, salbutamol and terbutaline were compared in 12 healthy individuals in a double-blind, placebo-controlled study. Measurements of heart rate, blood pressure, systolic time intervals, QTc interval and T-wave amplitude were made at baseline and at 15, 30, 45, 60 and 90 minutes after nebulisation. Fenoterol caused significantly greater chronotropic electrocardiographic and inotropic effects than either salbutamol or terbutaline. The peak effects after terbutaline occurred later than those after fenoterol or salbutamol.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2349198      PMCID： PMC2429517          DOI： 10.1136/pgmj.66.772.98

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  14 in total

Review 1.  Sympathomimetic bronchodilator drugs.

Authors:  R T Brittain; C M Dean; D Jack
Journal:  Pharmacol Ther B       Date:  1976

2.  75 deaths in asthmatics prescribed home nebulisers.

Authors:  M R Sears; H H Rea; J Fenwick; A J Gillies; P E Holst; T V O'Donnell; R P Rothwell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

3.  Evaluation of some non-invasive indices of cardiovascular function [proceedings].

Authors:  C D Burgess; J Wadsworth; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

4.  Asthma in New Zealand.

Authors:  I W Grant
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

5.  Asthma mortality in Birmingham 1975-7: 53 deaths.

Authors:  L P Ormerod; D E Stableforth
Journal:  Br Med J       Date:  1980-03-08

6.  The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist.

Authors:  M H Strauss; R A Reeves; D L Smith; F H Leenen
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

7.  Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.

Authors:  H H Vincent; F Boomsma; A J Man in't Veld; F H Derkx; G J Wenting; M A Schalekamp
Journal:  J Cardiovasc Pharmacol       Date:  1984 Jan-Feb       Impact factor: 3.105

8.  Cardiopulmonary effects of fenoterol and salbutamol aerosols.

Authors:  M K Tandon
Journal:  Chest       Date:  1980-03       Impact factor: 9.410

9.  Asthma mortality in New Zealand: a two year national study.

Authors:  M R Sears; H H Rea; R Beaglehole; A J Gillies; P E Holst; T V O'Donnell; R P Rothwell; D C Sutherland
Journal:  N Z Med J       Date:  1985-04-24

10.  Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.

Authors:  M L Greenberg; B B Lerman; J R Shipe; D L Kaiser; J P DiMarco
Journal:  J Am Coll Cardiol       Date:  1987-05       Impact factor: 24.094
View more
  6 in total

1.  The cardiovascular effects of beta adrenergic agonist drugs administered by nebulization.

Authors:  J A Hall
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

3.  Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.

Authors:  H E Montgomery; J Gill; C W Pumphrey
Journal:  Br Heart J       Date:  1994-08

4.  Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.

Authors:  E T Smyth; I D Pavord; C S Wong; A F Wisniewski; J Williams; A E Tattersfield
Journal:  BMJ       Date:  1993-02-27

5.  Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.

Authors:  C T Yang; H C Lin; M C Lin; C H Wang; C H Lee; H P Kuo
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  Short-term safety and tolerability of double-dose salmeterol/fluticasone propionate in adult asthmatic patients.

Authors:  Lars-Erik Adolfsson; Michael Lundgren; Bjorn Tilling; Sverker Jern; Christina Tyren; Alex Godwood; Dee Gor
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.